Showing results (141-150 of 158) with videos related to
Sort By:
Pageof 16
Cancers|November 26, 2022
ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In VivoYang Yu, Yanling Zhao, Jongmin Choi, et al.Oncotarget|February 9, 2018
MELK is a novel therapeutic target in high-risk neuroblastomaShan Guan, Jiaxiong Lu, Yanling Zhao, et al.Cancer Research|May 21, 2013
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenicDanielle M Hsu, Saurabh Agarwal, Ashley Benham, et al.Cell Reports|January 26, 2016
A Mouse Model of X-linked Intellectual Disability Associated with Impaired Removal of Histone MethylationShigeki Iwase, Emily Brookes, Saurabh Agarwal, et al.Respiratory Care|January 25, 2018
Perspectives on Incentive Spirometry Utility and Patient ProtocolsAdam E M Eltorai, Grayson L Baird, Ashley Szabo Eltorai, et al.Respiratory Care|January 25, 2018
Incentive Spirometry Adherence: A National Survey of Provider PerspectivesAdam E M Eltorai, Grayson L Baird, Ashley Szabo Eltorai, et al.Inquiry : a Journal of Medical Care Organization, Provision and Financing|September 4, 2018
Financial Impact of Incentive SpirometryAdam E M Eltorai, Grayson L Baird, Joshua Pangborn, et al.Cancer Letters|July 1, 2015
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastomaAnneleen Beckers, Gert Van Peer, Daniel R Carter, et al.JAMA Surgery|April 11, 2019
Effect of an Incentive Spirometer Patient Reminder After Coronary Artery Bypass Grafting: A Randomized Clinical TrialAdam E M Eltorai, Grayson L Baird, Ashley Szabo Eltorai, et al.Biorxiv : the Preprint Server for Biology|September 22, 2025
CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in NeuroblastomaYang Yu, Yanling Zhao, Zhongcheng Shi, et al.Pageof 16